QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
| |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) | |
|
| |
(Address of principal executive offices) |
(Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
|
|
Nasdaq Global Select Market |
|
☒ |
Accelerated filer |
☐ | |||
Non-accelerated filer |
☐ |
Smaller reporting company |
| |||
Emerging growth company |
|
ITEM 1. |
||||||
3 |
||||||
4 |
||||||
5 |
||||||
6 |
||||||
7 |
||||||
ITEM 2. |
35 |
|||||
ITEM 3. |
46 |
|||||
ITEM 4. |
46 |
|||||
ITEM 1. |
46 |
|||||
ITEM 1A. |
47 |
|||||
ITEM 6. |
48 |
|||||
49 |
ITEM 1. | FINANCIAL STATEMENTS. |
June 30, 2019 |
December 31, 2018 |
|||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | $ | ||||||
Short-term investments |
||||||||
Trade accounts receivable, net of allowance for doubtful accounts of $ |
||||||||
Inventories |
||||||||
Other current assets |
||||||||
Assets classified as held for sale |
— |
|||||||
Total current assets |
||||||||
Property, plant and equipment, net |
||||||||
Right-of-use asset |
— |
|||||||
Goodwill |
||||||||
Intangible assets, net |
||||||||
Long-term investments |
||||||||
Other assets |
||||||||
Total assets |
$ | $ | ||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY |
||||||||
Current liabilities: |
||||||||
Short-term debt |
$ | $ | ||||||
Accounts payable |
||||||||
Accrued compensation |
||||||||
Income taxes payable |
||||||||
Lease liability |
— |
|||||||
Deferred revenue and customer advances |
||||||||
Other current liabilities |
||||||||
Total current liabilities |
||||||||
Long-term debt, net |
||||||||
Non-current deferred taxes |
||||||||
Non-current accrued compensation |
||||||||
Non-current lease liability |
— |
|||||||
Other liabilities |
||||||||
Total liabilities |
||||||||
Commitments and contingencies (Note 19) |
||||||||
Stockholders’ equity: |
||||||||
Preferred Stock, $ |
— |
— |
||||||
Common Stock, |
||||||||
Additional paid-in capital |
||||||||
Retained earnings |
||||||||
Accumulated other comprehensive loss |
( |
) | ( |
) | ||||
Total stockholders’ equity |
||||||||
Total liabilities and stockholders’ equity |
$ | $ | ||||||
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
2019 |
2018 |
2019 |
2018 |
|||||||||||||
Net revenues: |
||||||||||||||||
Products |
$ | $ | $ | $ | ||||||||||||
Services |
||||||||||||||||
Total net revenues |
||||||||||||||||
Cost of revenues: |
||||||||||||||||
Cost of products |
||||||||||||||||
Cost of services |
||||||||||||||||
Total cost of revenues (exclusive of amortization shown separately below) |
||||||||||||||||
Gross profit |
||||||||||||||||
Research and development |
||||||||||||||||
Selling, general and administrative |
||||||||||||||||
Fees and expenses related to term loan |
— |
|||||||||||||||
Acquisition and integration costs |
( |
) | ( |
) | ||||||||||||
Restructuring and other |
||||||||||||||||
Amortization of intangible assets |
||||||||||||||||
Income from operations |
||||||||||||||||
Interest income |
||||||||||||||||
Interest expense |
||||||||||||||||
Other expense, net |
||||||||||||||||
Income before income taxes |
||||||||||||||||
Provision for income taxes |
||||||||||||||||
Net income |
$ | $ | $ | $ | ||||||||||||
Other comprehensive income: |
||||||||||||||||
Changes in value of financial instruments designated as cash flow hedges, net of tax (benefit) expense (1) |
$ | ( |
) | $ | $ | ( |
) | $ | ||||||||
Foreign currency translation adjustments, net of tax of $ |
( |
) | ( |
) | ( |
) | ||||||||||
Unrecognized pension gain (loss), net of tax (benefit) expense (2) |
( |
) | ||||||||||||||
Unrealized loss on investments, net of tax benefit (3) |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Total comprehensive income |
$ | $ | $ | $ | ||||||||||||
Net income per share: |
||||||||||||||||
Basic |
$ | $ | $ | $ | ||||||||||||
Diluted |
$ | $ | $ | $ | ||||||||||||
Weighted average common shares outstanding: |
||||||||||||||||
Basic |
||||||||||||||||
Diluted |
||||||||||||||||
(1) |
Tax (benefit) expense was $ ( and $( and $ |
(2) |
Tax (benefit) expense was $ ( and $( for the six months ended June 30, 2019 and 2018, respectively |
(3) |
Tax benefit was $ ( and $( for the three months ended June 30, 2019 and 2018, respectively. Tax benefit was $( and $( for the six months ended June 30, 2019 and 2018, respectively. |
Common Stock |
Additional Paid-In |
Retained |
Accumulated Other Comprehensive |
Total Stockholders’ |
||||||||||||||||||||
Shares |
Amount |
Capital |
Earnings |
Income/(Loss) |
Equity |
|||||||||||||||||||
Balance at December 31, 2018 |
|
$ | |
$ | |
$ | |
$ | ( |
) | $ | |
||||||||||||
Net issuance under stock-based plans |
|
|
|
|||||||||||||||||||||
Stock-based compensation |
|
|
||||||||||||||||||||||
Cash dividend ($ |
( |
) | ( |
) | ||||||||||||||||||||
Comprehensive income (net of tax): |
||||||||||||||||||||||||
Net income |
|
|
||||||||||||||||||||||
Other comprehensive loss |
( |
) | ( |
) | ||||||||||||||||||||
Balance at March 31, 2019 |
|
|
|
|
( |
) | |
|||||||||||||||||
Net issuance under stock-based plans |
|
( |
) | ( |
) | |||||||||||||||||||
Stock-based compensation |
|
|
||||||||||||||||||||||
Cash dividend ($ |
( |
) | ( |
) | ||||||||||||||||||||
Stock dividends accrued |
|
( |
) | — |
||||||||||||||||||||
Comprehensive income (net of tax): |
||||||||||||||||||||||||
Net income |
|
|
||||||||||||||||||||||
Other comprehensive loss |
( |
) | ( |
) | ||||||||||||||||||||
Balance at June 30, 2019 |
|
$ | |
$ | |
$ | |
$ | ( |
) | $ | |
||||||||||||
Common Stock |
Additional Paid-In |
Retained |
Accumulated Other Comprehensive |
Total Stockholders’ |
||||||||||||||||||||
Shares |
Amount |
Capital |
Earnings |
Income/(Loss) |
Equity |
|||||||||||||||||||
Balance at December 31, 2017 |
|
$ | |
$ | |
$ | |
$ | |
$ | |
|||||||||||||
Net issuance under stock-based plans |
|
( |
) | ( |
) | |||||||||||||||||||
Stock-based compensation |
|
|
||||||||||||||||||||||
Cash dividend ($ |
( |
) | ( |
) | ||||||||||||||||||||
Accounting Standards Codification Topic 606 adjustment |
|
|
||||||||||||||||||||||
Comprehensive income (net of tax): |
||||||||||||||||||||||||
Net income |
|
|
||||||||||||||||||||||
Other comprehensive gain |
|
|
||||||||||||||||||||||
Balance at March 31, 2018 |
|
|
|
|
|
|
||||||||||||||||||
Net issuance under stock-based plans |
|
( |
) | ( |
) | |||||||||||||||||||
Stock-based compensation |
|
|
||||||||||||||||||||||
Cash dividend ($ |
( |
) | ( |
) | ||||||||||||||||||||
Accounting Standards Codification Topic 606 adjustment |
( |
) | ( |
) | ||||||||||||||||||||
Comprehensive income (net of tax): |
||||||||||||||||||||||||
Net income |
|
|
||||||||||||||||||||||
Other comprehensive loss |
( |
) | ( |
) | ||||||||||||||||||||
Balance at June 30, 2018 |
|
$ | |
$ | |
$ | |
$ | |
$ | |
|||||||||||||
Six Months Ended June 30, |
||||||||
2019 |
2018 |
|||||||
Cash flows provided by operating activities: |
||||||||
Net income |
$ | |
$ | |
||||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||
Depreciation and amortization |
|
|
||||||
Amortization of inventory step-up adjustment to fair value |
|
— |
||||||
Amortization of debt issuance costs, original issue discount, and soft call premium |
|
|
||||||
Stock-based compensation |
|
|
||||||
Provision for excess and obsolete inventory |
|
|
||||||
(Recovery) provision for doubtful accounts |
( |
) | |
|||||
Deferred income taxes |
( |
) | |
|||||
Other |
|
|
||||||
Changes in operating assets and liabilities, net of business acquired: |
||||||||
Trade accounts receivable |
|
( |
) | |||||
Inventories |
( |
) | ( |
) | ||||
Income taxes |
( |
) | ( |
) | ||||
Other current and non-current assets |
( |
) | ( |
) | ||||
Accrued compensation |
( |
) | ( |
) | ||||
Other current and non-current liabilities |
( |
) | |
|||||
Accounts payable |
( |
) | |
|||||
Net cash provided by operating activities |
|
|
||||||
Cash flows used in investing activities: |
||||||||
Acquisition of business, net of cash acquired |
( |
) | — |
|||||
Purchases of investments |
( |
) | ( |
) | ||||
Maturities of investments |
|
|
||||||
Sales of investments |
|
|
||||||
Proceeds from sale of assets |
|
— |
||||||
Purchases of property, plant and equipment |
( |
) | ( |
) | ||||
Net cash used in investing activities |
( |
) | ( |
) | ||||
Cash flows provided by (used in) financing activities: |
||||||||
Net proceeds from short and long-term borrowings |
|
|
||||||
Payments on short-term borrowings |
( |
) | ( |
) | ||||
Payments on long-term borrowings |
( |
) | ( |
) | ||||
Net payments related to employee stock awards |
( |
) | ( |
) | ||||
Dividend payments to common stockholders |
( |
) | ( |
) | ||||
Net cash provided by (used in) financing activities |
|
( |
) | |||||
Effect of exchange rate changes on cash and cash equivalents |
( |
) | |
|||||
(Decrease) Increase in cash and cash equivalents and restricted cash |
( |
) | |
|||||
Cash and cash equivalents at beginning of period |
|
|
||||||
Cash and cash equivalents at end of period |
$ | |
$ | |
||||
1) | Basis of Presentation |
2) | Recently Issued Accounting Pronouncements |
3) | Leases |
Three Months Ended June 30, 2019 |
|
Six Months Ended June 30, 2019 |
| |||||
Lease Cost: |
|
|
|
| ||||
Operating lease cost |
$ | |
|
$ |
|
|
|
|
Amount |
| |
Year Ending December 31, |
|
|
| |
2019 (remaining) |
$ | |
||
2020 |
|
|||
2021 |
|
|||
2022 |
|
|||
2023 |
|
|||
Thereafter |
|
|||
Total lease payments |
|
|||
Less: imputed interest |
|
|||
Total operating lease liabilities |
$ | |
||
|
Operating Leases |
|||
Year Ending December 31, |
|
|
|
|
2019 |
$ | |
||
2020 |
|
|||
2021 |
|
|||
2022 |
|
|||
2023 |
|
|||
Thereafter |
|
|||
Total minimum lease payments |
$ | |
||
4) | Revenue from Contracts with Customers |
Contract assets as of June 30, 2019 and December 31, 2018 were $ |
Six Months Ended June 30, 2019 |
||||
Beginning balance, January 1 (1) |
$ | |
||
Deferred revenue and customer advances assumed in ESI Merger |
|
|||
Additions to deferred revenue and customer advances |
|
|||
Amount of deferred revenue and customer advances recognized in income |
( |
) | ||
Ending balance, June 30 (2) |
$ | |
||
(1) |
Beginning deferred revenue and customer advances as of January 1, 2019 included $ |
(2) |
Ending deferred revenue as of June 30, 2019 included $ |
Three Months Ended June 30, 2019 |
||||||||||||||||
Vacuum & Analysis |
Light & Motion |
Equipment & Solutions |
Total |
|||||||||||||
Net revenues: |
||||||||||||||||
Products |
$ | |
$ | |
$ | |
$ | |
||||||||
Services |
|
|
|
|
||||||||||||
Total net revenues |
$ | |
$ | |
$ | |
$ | |
||||||||
Three Months Ended June 30, 2018 |
||||||||||||||||
Vacuum & Analysis |
Light & Motion |
Equipment & Solutions |
Total |
|||||||||||||
Net revenues: |
||||||||||||||||
Products |
$ | |
$ | |
$ | — |
$ | |
||||||||
Services |
|
|
— |
|
||||||||||||
Total net revenues |
$ | |
$ | |
$ | — |
$ | |
||||||||
Six Months Ended June 30, 2019 |
||||||||||||||||
Vacuum & Analysis |
Light & Motion |
Equipment & Solutions |
Total |
|||||||||||||
Net revenues: |
||||||||||||||||
Products |
$ | |
$ | |
$ | |
$ | |
||||||||
Services |
|
|
|
|
||||||||||||
Total net revenues |
$ | |
$ | |
$ | |
$ | |
||||||||
Six Months Ended June 30, 2018 |
||||||||||||||||
Vacuum & Analysis |
Light & Motion |
Equipment & Solutions |
Total |
|||||||||||||
Net revenues: |
||||||||||||||||
Products |
$ | |
|
$ | — |
$ | |
|||||||||
Services |
|
|
— |
|
||||||||||||
Total net revenues |
$ | |
$ | |
$ | — |
$ | |
||||||||
5) | Investments |
June 30, 2019 |
December 31, 2018 |
|||||||
Available-for-sale investments: |
||||||||
Time deposits and certificates of deposit |
$ | |
$ | |
||||
Bankers’ acceptance drafts |
|
|
||||||
Asset-backed securities |
— |
|
||||||
Commercial paper |
|
|
||||||
Corporate obligations |
|
|
||||||
U.S. treasury obligations |
— |
|
||||||
U.S. agency obligations |
|
|
||||||
$ | |
$ | |
|||||
June 30, 2019 |
December 31, 2018 |
|||||||
Available-for-sale investments: |
||||||||
Group insurance contracts |
$ | |
$ | |
||||
Cost method investments: |
||||||||
Minority interest in a private company |
|
|
||||||
$ | |
$ | |
|||||
As of June 30, 2019: |
Cost |
Gross Unrealized Gains |
Gross Unrealized (Losses) |
Estimated Fair Value |
||||||||||||
Short-term investments: |
||||||||||||||||
Available-for-sale investments: |
||||||||||||||||
Time deposits and certificates of deposit |
$ | |
$ | |
$ | — |
$ | |
||||||||
Bankers’ acceptance drafts |
|
— |
— |
|
||||||||||||
Commercial paper |
|
— |
( |
) | |
|||||||||||
Corporate obligations |
|
|
— |
|
||||||||||||
U.S. agency obligations |
|
|
( |
) | |
|||||||||||
$ | |
$ | |
$ | ( |
) | $ | |
||||||||
As of June 30, 2019: |
Cost |
Gross Unrealized Gains |
Gross Unrealized (Losses) |
Estimated Fair Value |
||||||||||||
Long-term investments: |
||||||||||||||||
Available-for-sale investments: |
||||||||||||||||
Group insurance contracts |
$ | |
$ | |
$ | |
$ | |
||||||||
As of December 31, 2018: |
Cost |
Gross Unrealized Gains |
Gross Unrealized (Losses) |
Estimated Fair Value |
||||||||||||
Short-term investments: |
||||||||||||||||
Available-for-sale investments: |
||||||||||||||||
Time deposits and certificates of deposit |
$ | |
$ | — |
$ | — |
$ | |
||||||||
Bankers’ acceptance drafts |
|
— |
— |
|
||||||||||||
Asset-backed securities |
|
|
( |
) | |
|||||||||||
Commercial paper |
|
— |
( |
) | |
|||||||||||
Corporate obligations |
|
— |
( |
) | |
|||||||||||
U.S. treasury obligations |
|
|
— |
|
||||||||||||
U.S. agency obligations |
|
|
( |
) | |
|||||||||||
$ | |
$ | |
$ | ( |
) | $ | |
||||||||
As of December 31, 2018: |
Cost |
Gross Unrealized Gains |
Gross Unrealized (Losses) |
Estimated Fair Value |
||||||||||||
Long-term investments: |
||||||||||||||||
Available-for-sale investments: |
||||||||||||||||
Group insurance contracts |
$ | |
$ | |
$ | — |
$ | |
||||||||
In accordance with the provisions of fair value accounting, a fair value measurement assumes that the transaction to sell an asset or transfer a liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market for the asset or liability and defines fair value based upon an exit price model. |
Level 1 | Quoted prices in active markets for identical assets or liabilities assessed as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. |
Level 2 | Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 2 assets and liabilities include debt securities with quoted prices that are traded less frequently than exchange-traded instruments or securities or derivative contracts that are valued using a pricing model with inputs that are observable in the market or can be derived principally from or corroborated by observable market data. |
Level 3 | Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation. |
Fair Value Measurements at Reporting Date Using |
||||||||||||||||
Description |
June 30, 2019 |
Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Unobservable Inputs (Level 3) |
||||||||||||
Assets: |
||||||||||||||||
Cash equivalents: |
||||||||||||||||
Money market funds |
$ | |
$ | |
$ | — |
$ | — |
||||||||
Time deposits and certificates of deposit |
|
— |
|
— |
||||||||||||
Commercial paper |
|
— |
|
— |
||||||||||||
U.S. agency obligations |
|
— |
|
— |
||||||||||||
Restricted cash – money market funds |
|
|
— |
— |
||||||||||||
Available-for-sale investments: |
||||||||||||||||
Time deposits and certificates of deposit |
|
— |
|
— |
||||||||||||
Bankers’ acceptance drafts |
|
— |
|
— |
||||||||||||
Commercial paper |
|
— |
|
— |
||||||||||||
Corporate obligations |
|
— |
|
— |
||||||||||||
U.S. agency obligations |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— | | |
Group insurance contracts |
|
— |
|
— |
||||||||||||
Derivatives – currency forward contracts |
|
— |
|
— |
||||||||||||
Funds in investments and other assets: |
||||||||||||||||
Israeli pension assets |
|
— |
|
— |
||||||||||||
Deferred compensation plan assets: |
||||||||||||||||
Mutual funds and exchange traded funds |
|
— |
|
— |
||||||||||||
Money market securities |
|
— |
|
— |
||||||||||||
Total assets |
$ | |
$ | |
$ | |
$ | — |
||||||||
Liabilities: |
||||||||||||||||
Derivatives – currency forward contracts |
$ | |
$ | — |
$ | |
$ | — |
||||||||
Derivatives – interest rate hedge – non-current |
|
|
|
|
|
|
— |
|
|
|
|
|
|
|
— |
|
Total liabilities |
|
$ |
|
|
|
$ |
— |
|
|
$ |
|
|
|
$ |
— |
|
Reported as follows: |
||||||||||||||||
Assets: |
||||||||||||||||
Cash and cash equivalents, including restricted cash (1) |
$ | |
$ | |
$ | |
$ | — |
||||||||
Short-term investments |
|
— |
|
— |
||||||||||||
Other current assets |
|
— |
|
— |
||||||||||||
Total current assets |
$ | |
$ | |
$ | |
$ | — |
||||||||
Long-term investments (2) |
$ | |
$ | — |
$ | |
$ | — |
||||||||
Other assets |
|
— |
|
— |
||||||||||||
Total long-term assets |
$ | |
$ | — |
$ | |
$ | — |
||||||||
Liabilities: |
||||||||||||||||
Other current liabilities |
$ | |
$ | — |
$ | |
$ | — |
||||||||
Other liabilities |
|
$ |
|
|
|
$ |
— |
|
|
$ |
|
|
|
$ |
— |
|
(1) |
The cash and cash equivalent amounts presented in the table above do not include cash of $ |
(2) |
The long-term investments presented in the table above do not include the Company’s minority interest investment in a private company, which is accounted for under the cost method. |
Fair Value Measurements at Reporting Date Using |
||||||||||||||||
Description |
December 31, 2018 |
Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Unobservable Inputs (Level 3) |
||||||||||||
Assets: |
||||||||||||||||
Cash equivalents: |
||||||||||||||||
Money market funds |
$ | |
$ | |
$ | — |
$ | — |
||||||||
Time deposits and certificates of deposit |
|
— |
|
— |
||||||||||||
Commercial paper |
|
— |
|
— |
||||||||||||
U.S. agency obligations |
|
— |
|
— |
||||||||||||
Restricted cash – money market funds |
|
|
— |
— |
||||||||||||
Available-for-sale investments: |
||||||||||||||||
Time deposits and certificates of deposit |
|
— |
|
— |
||||||||||||
Bankers’ acceptance drafts |
|
— |
|
— |
||||||||||||
Asset-backed securities |
|
— |
|
— |
||||||||||||
Commercial paper |
|
— |
|
— |
||||||||||||
Corporate obligations |
|
— |
|
— |
||||||||||||
U.S. treasury obligations |
|
— |
|
— |
||||||||||||
U.S. agency obligations |
|
— |
|
— |
||||||||||||
Group insurance contracts |
|
— |
|
— |
||||||||||||
Derivatives – currency forward contracts |
|
— |
|
— |
||||||||||||
Funds in investments and other assets: |
||||||||||||||||
Israeli pension assets |
|
— |
|
— |
||||||||||||
Derivatives – interest rate hedge – non-current |
|
— |
|
— |
||||||||||||
Total assets |
$ | |
$ | |
$ | |
$ | — |
||||||||
Liabilities: |
||||||||||||||||
Derivatives – currency forward contracts |
$ | |
$ | — |
$ | |
$ | — |
||||||||
Reported as follows: |
||||||||||||||||
Assets: |
||||||||||||||||
Cash and cash equivalents, including restricted cash (1) |
$ | |
$ | |
$ | |
$ | — |
||||||||
Short-term investments |
|
— |
|
— |
||||||||||||
Other current assets |
|
— |
|
— |
||||||||||||
Total current assets |
$ | |
$ | |
$ | |
$ | — |
||||||||
Long-term investments (2) |
$ | |
$ | — |
$ | |
$ | — |
||||||||
Other assets |
|
— |
|
— |
||||||||||||
Total long-term assets |
$ | |
$ | — |
$ | |
$ | — |
||||||||
Liabilities: |
||||||||||||||||
Other current liabilities |
$ | |
$ | — |
$ | |
$ | — |
||||||||
(1) |
The cash and cash equivalent amounts presented in the table above do not include cash of $ |
(2) |
The long-term investments presented in the table above do not include the Company’s minority interest investment in a private company, which is accounted for under the cost method. |
7) | Derivatives |
June 30, 2019 |
||||||||
Currency Hedged (Buy/Sell) |
Gross Notional Value |
Fair Value (1) |
||||||
U.S. Dollar/Japanese Yen |
$ | $ | ( |
) | ||||
U.S. Dollar/South Korean Won |
||||||||
U.S. Dollar/Euro |
||||||||
U.S. Dollar/U.K. Pound Sterling |
||||||||
U.S. Dollar/Taiwan Dollar |
||||||||
Total |
$ | $ | ||||||
December 31, 2018 |
||||||||
Currency Hedged (Buy/Sell) |
Gross Notional Value |
Fair Value (1) |
||||||
U.S. Dollar/Japanese Yen |
$ | $ | ( |
) | ||||
U.S. Dollar/South Korean Won |
||||||||
U.S. Dollar/Euro |
||||||||
U.S. Dollar/U.K. Pound Sterling |
||||||||
U.S. Dollar/Taiwan Dollar |
||||||||
Total |
$ | $ | ||||||
(1) |
Represents the receivable (payable) amount included in the consolidated balance sheet. |
June 30, 2019 |
December 31, 2018 |
|||||||
Derivative assets: |
||||||||
Foreign exchange contracts (1) |
$ | $ | ||||||
Interest rate hedge (2) |
— |
|||||||
Derivative liabilities: |
||||||||
Foreign exchange contracts (1) |
( |
) | ( |
) | ||||
Interest rate hedge (2) |
( |
) |
— |
|||||
Total net derivative (liability) asset designated as hedging instruments |
$ | ( |
) | $ | ||||
(1) |
The derivative assets of $ |
(2) |
The interest rate hedge liability of $ |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
Derivatives Designated as Cash Flow Hedging Instruments |
2019 |
2018 |
2019 |
2018 |
||||||||||||
Forward exchange contracts: |
||||||||||||||||
Net gain (loss) recognized in OCI (1) |
$ | ( |
) | $ | |
$ | ( |
) | $ | |
||||||
Net gain (loss) reclassified from accumulated OCI into income (2) |
$ | |
$ | ( |
) | $ | |
$ | ( |
) |
(1) |
Net change in the fair value of the effective portion classified in OCI. |
|
|
(2) |
Effective portion classified in cost of products for the three and six months ended June 30, 2019 and 2018. The tax effect of the gains or losses reclassified from accumulated OCI into income is immaterial. |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
Derivatives Not Designated as Hedging Instruments |
2019 |
2018 |
2019 |
2018 |
||||||||||||
Forward exchange contracts: |
||||||||||||||||
Net gain (loss) recognized in income (1) |
$ | ( |
) | $ | |
$ | ( |
) | $ | |
(1) |
The Company enters into foreign exchange contracts to hedge against changes in the balance sheet for certain subsidiaries to mitigate the risk associated with certain foreign currency transactions in the ordinary course of business. These derivatives are not designated as hedging instruments and gains or losses from these derivatives are recorded immediately in other (expense) income. |
8) | Inventories |
June 30, 2019 |
December 31, 2018 |
|||||||
Raw materials |
$ | |
$ | |
||||
Work-in-process |
|
|
||||||
Finished goods |
|
|
||||||
$ | |
$ | |
|||||
9) | Acquisitions |
Cash paid for outstanding shares (1) |
$ | |
||
Settlement of share-based compensation awards (2) |
|
|||
Total purchase price |
|
|||
Less: Cash and cash equivalents acquired |
( |
) | ||
Total purchase price, net of cash and cash equivalents acquired |
$ | |
||
(1) |
Represents cash paid of $ |
|
|
(2) |
Represents the vested but not issued portion of ESI share-based compensation awards as of the acquisition date of February 1, 2019. |
Current assets (excluding inventory) |
$ | |
||
Inventory |
|
|||
Intangible assets |
|
|||
Goodwill |
|
|||
Property, plant and equipment |
|
|||
Long-term assets |
|
|||
Total assets acquired |
|
|||
Current liabilities |
|
|||
Non-current deferred taxes |
|
|||
Other long-term liabilities |
|
|||
Total liabilities assumed |
|
|||
Fair value of assets acquired and liabilities assumed |
|
|||
Less: Cash and cash equivalents acquired |
( |
) | ||
Total purchase price, net of cash and cash equivalents acquired |
$ | |
||
Completed technology - Laser |
$ | |
||
Completed technology - Non-Laser |
|
|||
Trademarks and trade names |
|
|||
Customer relationships |
|
|||
Backlog |
|
|||
$ | |
|||
Three Months Ended June 30, 2019 |
Six Months Ended June 30, 2019 |
|||||||
Total net revenues |
$ | |
$ | |
||||
Net loss |
$ | ( |
) | $ | ( |
) | ||
Net loss per share: |
||||||||
Basic |
$ | ( |
) | $ | ( |
) | ||
Diluted |
$ | ( |
) | $ | ( |
) | ||
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
2019 |
2018 |
2019 |
2018 |
|||||||||||||
Total net revenues |
$ | |
$ | $ | |
$ | |
|||||||||
Net income |
$ | |
$ | |
$ | |
$ | |
||||||||
Net income per share: |
||||||||||||||||
Basic |
$ | |
$ | |
$ | |
$ | |
||||||||
Diluted |
$ | |
$ | |
$ | |
$ | |
||||||||
(1) | Incremental amortization and depreciation expense related to the estimated fair value of identifiable intangible assets and property, plant and equipment, respectively, from the purchase price allocation. |
(2) | Revenue and cost of goods sold adjustments as a result of the reduction in deferred revenue and the cost related to their estimated fair value. |
(3) | Incremental interest expense related to the Company’s 2019 Incremental Term Loan Facility, as defined and discussed in Note 11. |
(4) | The exclusion of acquisition costs and inventory step-up amortization from the three and six month period ended June 30, 2019 and the addition of these items to the three and six month period ended June 30, 2018. |
(5) | The exclusion of debt issuance costs due to the modification of the 2019 Incremental Term Loan Facility from the three and six month period ended June 30, 2019 and the addition of this item to the three and six month period ended June 30, 2018. |
(6) | The estimated tax impact of the above adjustments. |
10) | Goodwill and Intangible Assets |
Six Months Ended June 30, 2019 |
Twelve Months Ended December 31, 2018 |
|||||||||||||||||||||||
Gross Carrying Amount |
Accumulated Impairment Loss |
Net |
Gross Carrying Amount |
Accumulated Impairment Loss |
Net |
|||||||||||||||||||
Beginning balance at January 1 |
$ | $ | ( |
) | $ | 586,996 |
$ | $ | ( |
) | $ | |||||||||||||
Acquired goodwill (1) |
472,695 |
— |
||||||||||||||||||||||
Foreign currency translation |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
Ending balance at June 30, 2019 and December 31, 2018 |
$ | $ | ( |
) | $ | 1,058,667 |
$ | $ | ( |
) | $ | 586,996 |
||||||||||||
(1) |
During the six months ended June 30, 2019, the Company recorded $ |
As of June 30, 2019: |
Gross |
Accumulated Impairment Charges |
Accumulated Amortization |
Foreign Currency Translation |
Net |
|||||||||||||||
Completed technology (1) |
$ | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | |||||||||
Customer relationships (1) |
( |
) | ( |
) | ( |
) | ||||||||||||||
Patents, trademarks, trade names and other (1) |
( |
) | ||||||||||||||||||
$ | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ||||||||||
(1) |
During the six months ended June 30, 2019, the Company recorded $ right-of-use asset line in the balance sheet. |
As of December 31, 2018: |
Gross |
Accumulated Impairment Charges |
Accumulated Amortization |
Foreign Currency Translation |
Net |
|||||||||||||||
Completed technology |
$ | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | |||||||||
Customer relationships |
( |
) | ( |
) | ( |
) | ||||||||||||||
Patents, trademarks, trade names and other |
( |
) | ( |
) | ||||||||||||||||
$ | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ||||||||||
Year |
Amount |
|||
2019 (remaining) |
$ | |||
2020 |
||||
2021 |
||||
2022 |
||||
2023 |
||||
2024 |
||||
Thereafter |
11) | Debt |
June 30, 2019 |
December 31, 2018 |
|||||||
Short-term debt: |
||||||||
Japanese lines of credit |
$ | |
$ | |
||||
Japanese receivables financing facility |
|
|
||||||
Other debt |
|
|
||||||
Term Loan Facility |
|
|
||||||
$ | |
$ | |
|||||
June 30, 2019 |
December 31, 2018 |
|||||||
Long-term debt: |
||||||||
Other debt |
$ | |
$ | |
||||
Term Loan Facility, net (1) |
|
|
||||||
$ | |
$ | |
|||||
(1) |
Net of deferred financing fees, original issuance discount and repricing fee of $ |
Year |
Amount |
|||
2019 (remaining) |
$ | |
||
2020 |
|
|||
2021 |
|
|||
2022 |
|
|||
2023 |
|
|||
2024 |
|
|||
Thereafter |
|
12) | Product Warranties |
Six Months Ended June 30, |
||||||||
2019 |
2018 |
|||||||
Beginning of period |
$ | |
$ | |
||||
Assumed product warranty liability from ESI Merger |
|
— |
||||||
Provision for product warranties |
|
|
||||||
Direct and other charges to warranty liability |
( |
) | ( |
) | ||||
End of period (1) |
$ | |
$ | |
||||
(1) |
As of June 30, 2019, short-term product warranty of $ |
13) | Income Taxes |
14) | Net Income Per Share |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
2019 |
2018 |
2019 |
2018 |
|||||||||||||
Numerator: |
||||||||||||||||
Net income |
$ | |
$ | |
$ | |
$ | |
||||||||
Denominator: |
||||||||||||||||
Shares used in net income per common share – basic |
54,815,000 |
54,719,000 |
54,481,000 |
54,571,000 |
||||||||||||
Effect of dilutive securities: |
||||||||||||||||
Restricted stock units, stock appreciation rights and shares issued under employee stock purchase plan |
|
|
|
|
||||||||||||
Shares used in net income per common share – diluted |
55,089,000 |
55,274,000 |
54,966,000 |
55,280,000 |
||||||||||||
Net income per common share: |
||||||||||||||||
Basic |
$ | |
$ | |
$ | |
$ | |
||||||||
Diluted |
$ | |
$ | |
$ | |
$ | |
15) | Stock-Based Compensation |
• | all RSUs that vest based solely on the satisfaction of service conditions, granted under any ESI equity plan, arrangement or agreement (“ESI Plan”) that were outstanding immediately prior to the effective time of the ESI Merger, and as to which shares of ESI common stock were not fully distributed in connection with the closing of the ESI Merger, |
• | all RSUs that were granted subject to vesting based on both the achievement of performance goals and the satisfaction of service conditions granted under any ESI Plan that were outstanding immediately prior to the effective time of the ESI Merger, and |
• | all SARs granted under any ESI Plan, whether vested or unvested, that were outstanding immediately prior to the effective time of the ESI Merger and held by an individual who was a service provider of ESI as of the date on which the effective time of the ESI Merger occurred. |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
2019 |
2018 |
2019 |
2018 |
|||||||||||||
Cost of revenues |
$ | |
$ | |
$ | |
$ | |
||||||||
Research and development expense |
|
|
|
|
||||||||||||
Selling, general and administrative expense |
|
|
|
|
||||||||||||
Acquisition and integration related expense |
|
— |
|
— |
||||||||||||
Total pre-tax stock-based compensation expense |
$ | |
$ | |
$ | |
$ | |
||||||||
Six Months Ended June 30, 2019 |
||||||||
Outstanding RSUs |
Weighted Average Grant Date Fair Value |
|||||||
RSUs – beginning of period |
|
$ | |
|||||
Assumed shares from ESI Merger |
|
$ | |
|||||
Accrued dividend shares |
|
$ | |
|||||
Granted |
|
$ | |
|||||
Vested |
( |
) | $ | |
||||
Forfeited |
( |
) | $ | |
||||
RSUs – end of period |
|
$ | |
|||||
Six Months Ended June 30, 2019 |
||||||||
Outstanding SARs |
Weighted Average Grant Date Fair Value |
|||||||
SARs – beginning of period |
|
$ | |
|||||
Assumed SARs from ESI Merger |
|
$ | |
|||||
Exercised |
( |
) | $ | |
||||
Forfeited or expired |
( |
) | $ | |
||||
SARs Outstanding – end of period |
|
$ | |
|||||
16) | Stockholders’ Equity |
17) | Business Segment, Geographic Area, Product and Significant Customer Information |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
2019 |
2018 |
2019 |
2018 |
|||||||||||||
Vacuum & Analysis |
$ | $ | $ | $ | ||||||||||||
Light & Motion |
||||||||||||||||
Equipment & Solutions |
— |
— |
||||||||||||||
$ | $ | $ | $ | |||||||||||||
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
2019 |
2018 |
2019 |
2018 |
|||||||||||||
Gross profit by reportable segment: |
||||||||||||||||
Vacuum & Analysis |
$ | $ | $ | $ | ||||||||||||
Light & Motion |
||||||||||||||||
Equipment & Solutions |
— |
|||||||||||||||
Total gross profit by reportable segment |
||||||||||||||||
Operating expenses: |
||||||||||||||||
Research and development |
||||||||||||||||
Selling, general and administrative |
||||||||||||||||
Fees and expenses related to term loan |
— |
|||||||||||||||
Acquisition and integration costs |
( |
) | ( |
) | ||||||||||||
Restructuring and other |
||||||||||||||||
Amortization of intangible assets |
||||||||||||||||
Income from operations |
||||||||||||||||
Interest and other expense, net |
||||||||||||||||
Income before income taxes |
||||||||||||||||
Provision for income taxes |
||||||||||||||||
Net income |
$ | $ | $ | $ | ||||||||||||
Vacuum & Analysis |
Light & Motion |
Equipment & Solutions |
Total |
|||||||||||||
Three Months Ended June 30, 2019: |
||||||||||||||||
Capital expenditures |
$ | $ | $ | $ | ||||||||||||
Six Months Ended June 30, 2019: |
||||||||||||||||
Capital expenditures |
$ | $ | $ | $ | ||||||||||||
Three Months Ended June 30, 2018: |
||||||||||||||||
Capital expenditures |
$ | $ | $ | — |
$ | |||||||||||
Six Months Ended June 30, 2018: |
||||||||||||||||
Capital expenditures |
$ | $ | $ | — |
$ | |||||||||||
Vacuum & Analysis |
Light & Motion |
Equipment & Solutions |
Total |
|||||||||||||
Three Months Ended June 30, 2019: |
||||||||||||||||
Depreciation and amortization |
$ | |
$ | |
$ | |
$ | |
||||||||
Six Months Ended June 30, 2019 |
||||||||||||||||
Depreciation and amortization |
$ | |
$ | |
$ | |
$ | |
||||||||
Three Months Ended June 30, 2018: |
||||||||||||||||
Depreciation and amortization |
$ | |
$ | |
$ | — |
$ | |
||||||||
Six Months Ended June 30, 2018: |
||||||||||||||||
Depreciation and amortization |
$ | |
$ | |
$ | — |
$ | |
||||||||
June 30, 2019: |
Vacuum & Analysis |
Light & Motion |
Equipment & Solutions |
Corporate, Eliminations & Other |
Total |
|||||||||||||||
Segment assets: |
||||||||||||||||||||
Trade accounts receivable |
$ | |
$ | |
$ | |
$ | ( |
) | $ | |
|||||||||
Inventories |
|
|
|
( |
) | |
||||||||||||||
Total segment assets |
$ | |
$ | |
$ | |
$ | ( |
) | $ | |
|||||||||
December 31, 2018: |
Vacuum & Analysis |
Light & Motion |
Equipment & Solutions |
Corporate, Eliminations & Other |
Total |
|||||||||||||||
Segment assets: |
||||||||||||||||||||
Trade accounts receivable |
$ | |
$ | |
$ | — |
$ | ( |
) | $ | |
|||||||||
Inventories |
|
|
— |
|
|
|||||||||||||||
Total segment assets |
$ | |
$ | |
$ | — |
$ | ( |
) | $ | |
|||||||||
June 30, 2019 |
December 31, 2018 |
|||||||
Total segment assets |
$ | |
$ | |
||||
Cash and cash equivalents and investments |
|
|
||||||
Other current assets |
|
|
||||||
Assets classified as held for sale |
|
|
|
|
|
|
— |
|
Property, plant and equipment, net |
|
|
||||||
Right-of-use asset |
|
— |
||||||
Goodwill and intangible assets, net |
|
|
||||||
Other assets |
|
|
||||||
Consolidated total assets |
$ | |
$ | |
||||
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
2019 |
2018 |
2019 |
2018 |
|||||||||||||
Net revenues: |
||||||||||||||||
United States |
$ | |
$ | |
$ | |
$ | |
||||||||
China |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Korea |
|
|
|
|
||||||||||||
Japan |
|
|
|
|
||||||||||||
Other Asia |
|
|
|
|
||||||||||||
Europe |
|
|
|
|
||||||||||||
$ | |
$ | |
$ | |
$ | |
|||||||||
June 30, 2019 |
December 31, 2018 |
|||||||
Long-lived assets: (1) |
||||||||
United States |
$ | |
$ | |
||||
Europe |
|
|
||||||
Asia |
|
|
||||||
$ | |
$ | |
|||||
(1) |
Long-lived assets include property, plant and equipment, net and certain other long-term assets, excluding long-term tax related accounts. |
June 30, 2019 |
December 31, 2018 |
|||||||
Reportable segment: |
||||||||
Vacuum & Analysis |
$ | |
$ | |
||||
Light & Motion |
|
|
||||||
Equipment & Solutions |
|
— |
||||||
Total goodwill |
$ | 1,058,667 |
$ | 586,996 |
||||
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
2019 |
2018 |
2019 |
2018 |
|||||||||||||
Advanced Manufacturing Components |
$ | |
$ | |
$ | |
$ | |
||||||||
Global Service |
|
|
|
|
||||||||||||
Advanced Manufacturing Systems |
|
— |
|
— |
||||||||||||
$ | |
$ | |
$ | |
$ | |
|||||||||
18) | Restructuring and Other |
Six Months Ended June 30, |
||||||||
2019 |
2018 |
|||||||
Beginning of period restructuring accrual |
$ | |
$ | |
||||
Charged to expense |
|
|
||||||
Payments and adjustments |
( |
) | ( |
) | ||||
End of period restructuring accrual |
$ | |
$ | |
||||
19) | Commitments and Contingencies |
20) | Assets Classified as Held for Sale |
ITEM 2. | MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
2019 |
2018 |
2019 |
2018 |
|||||||||||||
Net revenues: |
||||||||||||||||
Product |
84.7 |
% | 89.0 |
% | 85.2 |
% | 89.3 |
% | ||||||||
Services |
15.3 |
11.0 |
14.8 |
10.7 |
||||||||||||
Total net revenues |
100.0 |
100.0 |
100.0 |
100.0 |
||||||||||||
Cost of revenues: |
||||||||||||||||
Cost of product revenues |
47.7 |
46.5 |
48.6 |
46.8 |
||||||||||||
Cost of service revenues |
7.8 |
5.5 |
7.8 |
5.5 |
||||||||||||
Total cost of revenues (exclusive of amortization shown separately below) |
55.5 |
52.0 |
56.4 |
52.3 |
||||||||||||
Gross profit |
44.5 |
48.0 |
43.6 |
47.7 |
||||||||||||
Research and development |
8.8 |
6.4 |
8.6 |
6.3 |
||||||||||||
Selling, general and administrative |
17.6 |
13.4 |
17.7 |
14.1 |
||||||||||||
Fees and expenses related to term loan |
— |
— |
0.6 |
— |
||||||||||||
Acquisition and integration costs |
0.7 |
(0.2 |
) | 3.5 |
(0.1 |
) | ||||||||||
Restructuring and other |
0.2 |
0.1 |
0.3 |
0.3 |
||||||||||||
Amortization of intangible assets |
3.7 |
1.9 |
3.6 |
2.0 |
||||||||||||
Income from operations |
13.5 |
26.4 |
9.3 |
25.1 |
||||||||||||
Interest income |
0.3 |
0.3 |
0.3 |
0.2 |
||||||||||||
Interest expense |
2.7 |
0.7 |
2.3 |
0.8 |
||||||||||||
Other expense, net |
0.1 |
0.1 |
0.1 |
0.1 |
||||||||||||
Income from operations before income taxes |
11.0 |
25.9 |
7.2 |
24.4 |
||||||||||||
Provision for income taxes |
3.0 |
4.5 |
1.8 |
4.2 |
||||||||||||
Net income |
8.0 |
% | 21.4 |
% | 5.4 |
% | 20.2 |
% | ||||||||
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
(dollars in millions) |
2019 |
2018 |
2019 |
2018 |
||||||||||||
Product |
$ | 401.3 |
$ | 510.0 |
$ | 798.7 |
$ | 1,006.7 |
||||||||
Service |
72.8 |
63.1 |
139.0 |
120.7 |
||||||||||||
Total net revenues |
$ | 474.1 |
$ | 573.1 |
$ | 937.7 |
$ | 1,127.4 |
||||||||
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
(dollars in millions) |
2019 |
2018 |
2019 |
2018 |
||||||||||||
Net revenues: |
||||||||||||||||
Vacuum & Analysis |
$ | 235.6 |
$ | 368.3 |
$ | 470.0 |
$ | 716.7 |
||||||||
Light & Motion |
182.6 |
204.8 |
376.6 |
410.7 |
||||||||||||
Equipment & Solutions |
55.9 |
— |
91.1 |
— |
||||||||||||
Total net revenues |
$ | 474.1 |
$ | 573.1 |
$ | 937.7 |
$ | 1,127.4 |
||||||||
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||||||||||
2019 |
2018 |
% Points Change |
2019 |
2018 |
% Points Change |
|||||||||||||||||||
Gross profit as a percentage of net revenues: |
||||||||||||||||||||||||
Product |
43.6 |
% | 47.7 |
% | (4.1 |
)% | 42.9 |
% | 47.5 |
% | (4.6 |
)% | ||||||||||||
Service |
49.3 |
50.3 |
(1.0 |
) | 47.8 |
49.1 |
(1.3 |
) | ||||||||||||||||
Total gross profit |
44.5 |
% | 48.0 |
% | (3.5 |
)% | 43.6 |
% | 47.7 |
% | (4.1 |
)% | ||||||||||||
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||||||||||
2019 |
2018 |
% Points Change |
2019 |
2018 |
% Points Change |
|||||||||||||||||||
Gross profit as a percentage of net revenues: |
||||||||||||||||||||||||
Vacuum & Analysis |
43.3 |
% | 46.4 |
% | (3.1 |
)% | 42.5 |
% | 46.0 |
% | (3.5 |
)% | ||||||||||||
Light & Motion |
45.7 |
50.7 |
(5.0 |
) | 46.8 |
50.7 |
(3.9 |
) | ||||||||||||||||
Equipment & Solutions |
44.5 |
— |
100.0 |
35.3 |
— |
100.0 |
||||||||||||||||||
Total gross profit |
44.5 |
% | 48.0 |
% | (3.5 |
)% | 43.6 |
% | 47.7 |
% | (4.1 |
)% | ||||||||||||
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
(dollars in millions) |
2019 |
2018 |
2019 |
2018 |
||||||||||||
Research and development expenses |
$ | 41.9 |
$ | 36.5 |
$ | 80.8 |
$ | 71.4 |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
(dollars in millions) |
2019 |
2018 |
2019 |
2018 |
||||||||||||
Selling, general and administrative expenses |
$ | 83.2 |
$ | 76.2 |
$ | 165.7 |
$ | 159.1 |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
(dollars in millions) |
2019 |
2018 |
2019 |
2018 |
||||||||||||
Fees and expenses related to term loan |
$ | — |
$ | 0.4 |
$ | 5.8 |
$ | 0.4 |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
(dollars in millions) |
2019 |
2018 |
2019 |
2018 |
||||||||||||
Acquisition and integration costs |
$ | 3.2 |
$ | (1.2 |
) | $ | 33.4 |
$ | (1.2 |
) |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
(dollars in millions) |
2019 |
2018 |
2019 |
2018 |
||||||||||||
Restructuring and other |
$ | 1.2 |
$ | 0.8 |
$ | 3.2 |
$ | 3.0 |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
(dollars in millions) |
2019 |
2018 |
2019 |
2018 |
||||||||||||
Amortization of intangible assets |
$ | 17.6 |
$ | 10.9 |
$ | 33.3 |
$ | 22.1 |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
(dollars in millions) |
2019 |
2018 |
2019 |
2018 |
||||||||||||
Interest expense, net |
$ | 11.3 |
$ | 2.5 |
$ | 18.7 |
$ | 6.8 |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
(dollars in millions) |
2019 |
2018 |
2019 |
2018 |
||||||||||||
Other expense, net |
$ | 0.8 |
$ | 0.3 |
$ | 1.1 |
$ | 0.9 |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
(dollars in millions) |
2019 |
2018 |
2019 |
2018 |
||||||||||||
Provision for income taxes |
$ | 14.1 |
$ | 25.7 |
$ | 17.0 |
$ | 47.3 |
ITEM 3. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK. |
ITEM 4. | CONTROLS AND PROCEDURES. |
ITEM 1. | LEGAL PROCEEDINGS. |
ITEM 1A. | RISK FACTORS. |
ITEM 6. | EXHIBITS. |
Exhibit No. |
Exhibit Description | |||
+3.1(1) |
||||
+3.2(2) |
||||
+3.3(3) |
||||
+3.4(4) |
||||
10.1 |
||||
*10.2 |
||||
31.1 |
||||
31.2 |
||||
32.1 |
||||
101.INS |
XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | |||
101.SCH |
XBRL Taxonomy Extension Schema Document | |||
101.CAL |
XBRL Taxonomy Extension Calculation Linkbase Document | |||
101.LAB |
XBRL Taxonomy Extension Label Linkbase Document | |||
101.PRE |
XBRL Taxonomy Extension Presentation Linkbase Document | |||
101.DEF |
XBRL Taxonomy Extension Definition Linkbase Document |
+ | Previously filed |
* | Management contract or compensatory plan arrangement |
(1) | Incorporated by reference to the Registration Statement on Form S-4 333-49738), |
(2) | Incorporated by reference to the Registrant’s Quarterly Report on Form 10-Q 000-23621), |
(3) | Incorporated by reference to the Registrant’s Quarterly Report on Form 10-Q 000-23621), |
(4) | Incorporated by reference to the Registrant’s Current Report on Form 8-K 000-23621), |
MKS INSTRUMENTS, INC. | ||||||
Date: August 7, 2019 |
By: |
/s/ Seth H. Bagshaw | ||||
Seth H. Bagshaw | ||||||
Senior Vice President, Chief Financial Officer and Treasurer | ||||||
(Principal Financial Officer) |